Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...
A gene linked to obesity in Labradors is the same one found in humans, scientists say. The discovery could help researchers ...
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
5h
ScienceAlert on MSNNew Protein Discovery Could Rival Ozempic With Fewer Side EffectsScientists have discovered a naturally-occurring molecule that aids appetite control and weight loss so well, it may compete ...
In a statement, Trotter described his experience as a child with older relatives who struggled with Type 2 diabetes. Trotter ...
14h
WHTM Harrisburg on MSNPennsylvania lawmakers debate having Medicaid cover Ozempic, similar drugsBudget hearings are over at the State Capitol, but one particular expense involving a popular weight loss drug has caught the ...
12h
Discover Magazine on MSNNew Molecule Competes with Ozempic, Showing Fewer Side EffectsA naturally occurring molecule that works as effectively as other semaglutide-based drugs - without the common side effects - ...
CagriSema, which is a combination of cagrilintide 2.4-milligram and semaglutide 2.4-mg doses, is being developed so people have a better choice for a weight-loss drug when the patents on Ozempic and ...
Novo’s share price fell 8 per cent on Monday, having previously dived in December after a late-stage trial of CagriSema in overweight or obese people without diabetes found they lost an average of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results